Published in Nucl Med Commun on December 01, 2009
Cholecystectomy for biliary dyskinesia: how did we get there? Dig Dis Sci (2014) 0.79
AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging (2003) 8.56
Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel (2006) 3.27
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A (2010) 2.89
Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial. J Nucl Med (2012) 2.88
Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest (2011) 2.69
Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. J Nucl Med (2009) 2.66
Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat Methods (2007) 2.64
Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol (2009) 2.58
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology (2010) 2.32
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc Natl Acad Sci U S A (2002) 2.01
Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug Chem (2005) 2.01
Ultrahigh sensitivity carbon nanotube agents for photoacoustic molecular imaging in living mice. Nano Lett (2010) 2.00
Design and evaluation of a variable aperture collimator for conformal radiotherapy of small animals using a microCT scanner. Med Phys (2007) 1.90
Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology (2008) 1.88
Radiation-luminescence-excited quantum dots for in vivo multiplexed optical imaging. Small (2010) 1.87
Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature. Nano Lett (2008) 1.85
Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med (2007) 1.85
64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression. Bioconjug Chem (2007) 1.79
Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem (2006) 1.75
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. J Nucl Med (2006) 1.74
Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res (2007) 1.74
Uptake kinetics and biodistribution of 14C-D-luciferin--a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging. Eur J Nucl Med Mol Imaging (2008) 1.64
Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy. Eur J Nucl Med Mol Imaging (2011) 1.63
Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules. J Nucl Med (2008) 1.63
Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. Mol Ther (2003) 1.62
Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging. Radiology (2011) 1.61
Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med (2010) 1.57
Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med (2003) 1.57
90Y-ibritumomab therapy in refractory non-Hodgkin's lymphoma: observations from 111In-ibritumomab pretreatment imaging. J Nucl Med (2008) 1.56
Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging. Eur Radiol (2010) 1.54
Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells (2007) 1.54
Design, synthesis, and imaging of an activatable photoacoustic probe. J Am Chem Soc (2010) 1.52
Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47
Crystal structures of the luciferase and green fluorescent protein from Renilla reniformis. J Mol Biol (2007) 1.44
Lower extremity CT angiography (CTA): initial evaluation of a knowledge-based centerline estimation algorithm for femoro-popliteal artery (FPA) occlusions. Acad Radiol (2009) 1.40
Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects. Cancer Res (2009) 1.38
Characterization of basal hepatic bile flow and the effects of intravenous cholecystokinin on the liver, sphincter, and gallbladder in patients with sphincter of Oddi spasm. Eur J Nucl Med Mol Imaging (2003) 1.38
Shape matters: intravital microscopy reveals surprising geometrical dependence for nanoparticles in tumor models of extravasation. Nano Lett (2012) 1.37
Imaging gene expression in human mesenchymal stem cells: from small to large animals. Radiology (2009) 1.37
Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases. Mol Imaging Biol (2012) 1.37
Noninvasive imaging of protein-protein interactions from live cells and living subjects using bioluminescence resonance energy transfer. FASEB J (2005) 1.36
Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke (2011) 1.34
MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res (2011) 1.32
Cetuximab-based immunotherapy and radioimmunotherapy of head and neck squamous cell carcinoma. Clin Cancer Res (2010) 1.29
Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med (2010) 1.28
Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. J Nucl Med (2010) 1.27
Synthesis and radioluminescence of PEGylated Eu(3+) -doped nanophosphors as bioimaging probes. Adv Mater (2011) 1.26
BRET3: a red-shifted bioluminescence resonance energy transfer (BRET)-based integrated platform for imaging protein-protein interactions from single live cells and living animals. FASEB J (2009) 1.25
An improved bioluminescence resonance energy transfer strategy for imaging intracellular events in single cells and living subjects. Cancer Res (2007) 1.25
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography. Chest (2006) 1.23
Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. J Nucl Med (2005) 1.23
Bioluminescent monitoring of islet graft survival after transplantation. Mol Ther (2004) 1.21
Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog. J Nucl Med (2007) 1.16
Photoacoustic ocular imaging. Opt Lett (2010) 1.16
A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000. J Natl Cancer Inst Monogr (2006) 1.15
Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging. Circ Cardiovasc Imaging (2012) 1.13
Controlling the selection stringency of phage display using a microfluidic device. Lab Chip (2009) 1.12
Image-guided cardiac cell delivery using high-resolution small-animal ultrasound. Mol Ther (2005) 1.11
Monitoring caspase-3 activation with a multimodality imaging sensor in living subjects. Clin Cancer Res (2008) 1.10
Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival. Nat Med (2006) 1.10
Ovarian cancer early detection claims are biased. Clin Cancer Res (2008) 1.10
A red-shifted Renilla luciferase for transient reporter-gene expression. Nat Methods (2010) 1.10
Early detection of sporadic pancreatic cancer: summative review. Pancreas (2015) 1.10
64Cu-labeled affibody molecules for imaging of HER2 expressing tumors. Mol Imaging Biol (2009) 1.10
Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med (2008) 1.09
Molecular photoacoustic imaging of follicular thyroid carcinoma. Clin Cancer Res (2013) 1.06
Dynamic PET/CT with 11C-acetate in prostate cancer. J Nucl Med (2012) 1.06
Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy. Small (2010) 1.05
Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem (2007) 1.05
Endoscopic imaging of Cerenkov luminescence. Biomed Opt Express (2012) 1.05
Brain tumors. Semin Nucl Med (2012) 1.05
The dangling diaphragm sign: sensitivity and comparison with existing CT signs of blunt traumatic diaphragmatic rupture. Emerg Radiol (2009) 1.04
Noninvasive imaging of islet grafts using positron-emission tomography. Proc Natl Acad Sci U S A (2006) 1.04
Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology (2012) 1.03
Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects. Cancer Res (2008) 1.03
Molecular imaging applications for immunology. Clin Immunol (2004) 1.02
Transferring biomarker into molecular probe: melanin nanoparticle as a naturally active platform for multimodality imaging. J Am Chem Soc (2014) 1.01
Discordance rates between preliminary and final radiology reports on cross-sectional imaging studies at a level 1 trauma center. Acad Radiol (2008) 1.00
Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives. Clin Breast Cancer (2003) 1.00
FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging (2002) 0.99
Multimodality imaging of T-cell hybridoma trafficking in collagen-induced arthritic mice: image-based estimation of the number of cells accumulating in mouse paws. J Biomed Opt (2007) 0.99
Multimodality imaging of β-cells in mouse models of type 1 and 2 diabetes. Diabetes (2011) 0.99
Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway. Eur J Nucl Med Mol Imaging (2010) 0.99
Segmentation of the gallbladder: effect on bile entry and exit and its clinical relevance in a patient with abdominal pain. Nucl Med Commun (2007) 0.98
An engineered knottin peptide labeled with 18F for PET imaging of integrin expression. Bioconjug Chem (2009) 0.98
Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe. PLoS One (2011) 0.97
Stem cell-mediated accelerated bone healing observed with in vivo molecular and small animal imaging technologies in a model of skeletal injury. J Orthop Res (2009) 0.97
Imaging tumor angiogenesis: the road to clinical utility. AJR Am J Roentgenol (2013) 0.96
Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest (2005) 0.96
Strains across the acetabular labrum during hip motion: a cadaveric model. Am J Sports Med (2011) 0.95
Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection. Radiology (2014) 0.95
False-negative diagnoses at stereotactic vacuum-assisted needle breast biopsy: long-term follow-up of 1,280 lesions and review of the literature. AJR Am J Roentgenol (2009) 0.94
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases. Clin Nucl Med (2013) 0.94
Long-term monitoring of transplanted islets using positron emission tomography. Mol Ther (2006) 0.93
Polyp enhancing level set evolution of colon wall: method and pilot study. IEEE Trans Med Imaging (2007) 0.93
Improving image quality by accounting for changes in water temperature during a photoacoustic tomography scan. PLoS One (2012) 0.93
The impact of PET on the management of lung cancer: the referring physician's perspective. J Nucl Med (2002) 0.93
Synthesis of 2'-deoxy-2'-[18F]fluoro-9-β-D-arabinofuranosylguanine: a novel agent for imaging T-cell activation with PET. Mol Imaging Biol (2011) 0.92